{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T06:47:42Z","timestamp":1768027662174,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.05.049","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T05:05:04Z","timestamp":1181797504000},"page":"5958-5967","source":"Crossref","is-referenced-by-count":30,"title":["A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination"],"prefix":"10.1016","volume":"25","author":[{"given":"Juliana","family":"Cassataro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina A.","family":"Pasquevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia M.","family":"Estein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego A.","family":"Laplagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Zwerdling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"de la Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo H.","family":"Giambartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.05.049_bib1","unstructured":"FAO-WHO."},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.049_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.049_bib3","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.049_bib4","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.049_bib5","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.049_bib6","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase","volume":"279","author":"Zylberman","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.049_bib7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.049_bib8","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.176.4.2366","article-title":"A polymeric bacterial protein activates dendritic cells via TLR4","volume":"176","author":"Berguer","year":"2006","journal-title":"J Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.05.049_bib9","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.049_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB\/c mice","volume":"5","author":"Estein","year":"2003","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.049_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0264-410X(98)00205-9","article-title":"Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB\/c mice","volume":"17","author":"Guilloteau","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.049_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/prot.20248","article-title":"Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides","volume":"57","author":"Laplagne","year":"2004","journal-title":"Proteins"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.049_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1099\/00222615-48-9-833","article-title":"The 18-kDa cytoplasmic protein of Brucella species \u2013 an antigen useful for diagnosis \u2013 is a lumazine synthase","volume":"48","author":"Goldbaum","year":"1999","journal-title":"J Med Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.049_bib14","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/JCM.30.12.3168-3174.1992","article-title":"Antibody response to Brucella outer membrane proteins in bovine brucellosis: immunoblot analysis and competitive enzyme-linked immunosorbent assay using monoclonal antibodies","volume":"30","author":"Cloeckaert","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.049_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CDLI.11.1.111-114.2004","article-title":"Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae","volume":"11","author":"Cassataro","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.049_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.05.049_bib17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0264-410X(94)90035-3","article-title":"Modulation of immune responses in Balb\/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine","volume":"12","author":"Tabatabai","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.049_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/0022-1317-49-2-165","article-title":"Identification and partial characterisation of a new protective antigen of Brucella abortus","volume":"49","author":"Cespedes","year":"2000","journal-title":"J Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.049_bib19","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.05.049_bib20","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis by DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.05.049_bib21","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0264-410X(01)00498-4","article-title":"Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA","volume":"20","author":"Cassataro","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.049_bib22","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.4049\/jimmunol.163.12.6756","article-title":"A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms","volume":"163","author":"Aberle","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.049_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/intimm\/9.12.1897","article-title":"Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization","volume":"9","author":"Boyle","year":"1997","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.049_bib24","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1128\/JVI.73.12.10214-10223.1999","article-title":"Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response","volume":"73","author":"Lewis","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.049_bib25","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.169.9.4951","article-title":"Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways","volume":"169","author":"Rush","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.049_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/jmbi.2000.3640","article-title":"Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus","volume":"297","author":"Braden","year":"2000","journal-title":"J Mol Biol"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2007.05.049_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.049_bib28","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/IAI.64.9.3744-3751.1996","article-title":"Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein","volume":"64","author":"Vizcaino","year":"1996","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.049_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/IAI.62.2.632-638.1994","article-title":"Protective immunity to Brucella ovis in BALB\/c mice following recovery from primary infection or immunization with subcellular vaccines","volume":"62","author":"Jimenez de Bagues","year":"1994","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.049_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1099\/00222615-34-3-175","article-title":"Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella","volume":"34","author":"Cloeckaert","year":"1991","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.049_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1099\/00222615-37-2-100","article-title":"Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella","volume":"37","author":"Jacques","year":"1992","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.049_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"6603","key":"10.1016\/j.vaccine.2007.05.049_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T02:32:16Z","timestamp":1707964336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":33,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006299"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.05.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}